We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 486.00
Bid: 485.50
Ask: 489.00
Change: 0.00 (0.00%)
Spread: 3.50 (0.721%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 486.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Apr 2018 07:00

RNS Number : 8730J
Treatt PLC
05 April 2018
 

 

 

5 April 2018

 

TREATT PLC

("Treatt" or "the Group")

 

Trading Update for the half year ended 31 March 2018

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the half year ended 31 March 2018.

 

The Board is pleased to confirm that following a strong result for the financial year ended 30 September 2017 in which profit before tax increased by 46%, the business has continued to perform well in the current financial year with revenue for the six months ended 31 March 2018 up by approximately 11% compared to the same period in the prior year.

 

The core business categories of citrus, tea and sugar reduction have continued to drive top-line growth with the combined effect of new business wins in the prior year, together with further wins in the current year, beginning to take hold.

 

Whilst the Group has in place a hedging strategy to try to ensure that the impact of exchange rate movements is broadly neutral to the income statement over the course of a financial year, as has been experienced previously, there can be material effects over shorter periods of time. In the first half of the current financial year ("H1 2018") there was a weakening in the USD/GBP exchange rate and as a result the Board anticipates that there will be a small negative net FX impact on the H1 2018 results of approximately £0.2m.

 

The recently enacted Tax Cuts and Jobs Act in the United States is expected to result in a material reduction in the Group's overall tax charge. Firstly, the reduction in the headline federal income tax rate from 35% to 21% will reduce the current tax rate on the Group's US profits to 24.5% and further reduce the tax rate to 21% for the financial year ending 30 September 2019. In addition, the Board expects a one-off deferred tax credit of approximately $0.5m (£0.4m). The US tax charge is also likely to be reduced further under the Foreign Derived Intangible Income Tax regime on exports out of the US business. The Group will continue to work through the full impact of these changes as further guidance becomes available, but it is expected that the Group's overall tax charge will be materially lower than would have been the case under previous US tax law.

 

Outlook

The momentum which is being delivered by the Board's Strategic Plan, with its focus on core product categories and key geographical markets, is expected to continue in the second half of the current financial year and beyond. The Board therefore continues to believe that profit before tax and exceptional items will be in line with its expectations for the financial year ending 30 September 2018.

 

The Board expects to announce Treatt's half year results for the six months ended 31 March 2018 on 8 May 2018.

 

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3865 5971

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

 

 

 

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDSAISIIT
Date   Source Headline
7th May 20203:48 pmRNSHolding(s) in Company
6th May 20204:23 pmRNSHolding(s) in Company
29th Apr 202012:51 pmRNSDisclosure of rights attached to equity shares
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:03 pmRNSPrice Monitoring Extension
24th Apr 20202:12 pmRNSHolding(s) in Company
23rd Apr 20206:23 pmRNSDirector/PDMR Shareholding
17th Apr 20202:06 pmRNSSID and Board Committee Changes
14th Apr 20204:36 pmRNSHolding(s) in Company
9th Apr 20204:43 pmRNSHolding(s) in Company
9th Apr 20204:19 pmRNSTR:1 notification of major holdings
7th Apr 20207:00 amRNSTrading update
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20205:15 pmRNSDirector/PDMR Shareholding
23rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 202010:38 amRNSHolding(s) in Company
12th Mar 20204:40 pmRNSPrice Monitoring Extension
18th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:29 pmRNSHolding(s) in Company
6th Feb 20209:04 amRNSHolding(s) in Company
5th Feb 20203:53 pmRNSVoting Rights and Capital
31st Jan 20204:54 pmRNSResult of AGM
29th Jan 20205:26 pmRNSDirector/PDMR Shareholding
29th Jan 20205:10 pmRNSHolding(s) in Company
21st Jan 20203:21 pmRNSHolding(s) in Company
21st Jan 20201:26 pmRNSHolding(s) in Company
17th Jan 20203:28 pmRNSDirector/PDMR Shareholding
16th Jan 20205:07 pmRNSHolding(s) in Company
9th Jan 20202:28 pmRNSDirector/PDMR Shareholding - Replacement
8th Jan 20205:04 pmRNSDirector/PDMR Shareholding
7th Jan 20205:16 pmRNSHolding(s) in Company
6th Jan 202011:18 amRNSDirector/PDMR Shareholding
24th Dec 201910:54 amRNSVoting Rights and Capital
18th Dec 20194:03 pmRNSNotification of Transactions of Directors
17th Dec 20194:04 pmRNSDirector/PDMR Shareholding
10th Dec 201912:15 pmRNSAnnual Report
6th Dec 20194:12 pmRNSHolding(s) in Company
2nd Dec 20194:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Dec 20194:43 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Nov 20197:00 amRNSFinal Results
25th Nov 201912:07 pmRNSSecond Price Monitoring Extn
25th Nov 201912:02 pmRNSPrice Monitoring Extension
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
21st Nov 20193:11 pmRNSBoard Committee Change
6th Nov 20199:44 amRNSHolding(s) in Company
25th Oct 20194:40 pmRNSSecond Price Monitoring Extn
25th Oct 20194:35 pmRNSPrice Monitoring Extension
4th Oct 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.